Technology Solutions

Bracket launches CUBE, an IRT Solution

Tuesday, June 6, 2017

Bracket, a clinical trial technology and specialty services provider, announced the release of CUBE, a transformative interactive response technology (IRT) solution for the life sciences industry. Designed through an iterative user acceptance build experience, CUBE will be immediately available to qualifying biotechnology and pharmaceutical trial sponsors through Bracket.

[Read More]

TraceLink releases automated validation manager

Tuesday, June 6, 2017

TraceLink, a Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, announced Automated Validation Manager (AVM)—a web-based offering that automates the entire validation lifecycle of the TraceLink Life Sciences Cloud on an ongoing basis.

[Read More]

Certara launches CODEx

Tuesday, June 6, 2017

Certara, a provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, launched its Clinical Outcomes Database Explorer (CODEx). An intuitive, web-based platform, CODEx enables drug development teams to easily visualize, explore, analyze and communicate content from Certara’s Clinical Trial Outcomes Databases and assess a given compound’s probability of success against competitor drugs.

[Read More]

Bristol-Myers Squibb, QIAGEN ink NGS technology agreement

Monday, June 5, 2017

Bristol-Myers Squibb and QIAGEN have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as predictive or prognostic tools for use with Bristol-Myers Squibb novel immuno-oncology (I-O) therapies in cancer treatment. This will leverage the combination of Bristol-Myers Squibb’s portfolio of I-O therapies with QIAGEN’s proven track record in developing and commercializing companion and complementary diagnostics as well as QIAGEN’s portfolio of NGS technologies. I-O therapies offer a novel way to treat cancer by using drugs to target the body’s immune system to help fight cancer.

[Read More]

DocSynk’s AI-powered app winner in GE Health Cloud Innovation Challenge

Friday, June 2, 2017

DocSynk, a healthcare machine learning and artificial intelligence (AI) platform, has announced that its new AI-powered cloud-based app for the healthcare industry has received the “Popular Choice” award in the GE Health Cloud Innovation Challenge, a competition among Independent Software Vendors (ISVs) to develop a cloud-based application that has the greatest potential to improve clinical, financial and/or operational outcomes in healthcare.  The company also received an “Honorable Mention” in the Operational Category.

[Read More]

Orbita, ERT collaborate to optimize data capture

Tuesday, May 23, 2017

Orbita, a provider of voice-first software for connected home healthcare, announced a collaboration with ERT to research innovative new approaches to data procurement and management for pharmaceutical and device customers seeking to streamline clinical trials. The collaboration combines the advanced capabilities of ERT’s EXPERT technology platform for clinical trial data collection, processing, and analysis with Orbita Voice, a first-of-its-kind solution for creating conversational applications using intelligent voice agents such as Amazon Alexa and Google Assistant.

[Read More]

ERT launches Solution for Lung Clearance Index (LCI)

Monday, May 22, 2017

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, introduced an advanced respiratory clinical trial solution to centrally capture, measure and analyze Lung Clearance Index data, in near real-time, to assess lung performance with more precision than traditional spirometry measures.

[Read More]